Yousefi H, Khosla M, Lauterboeck L, Okpechi SC, et al. Correction to: A combination of novel NSC small molecule inhibitor along with doxorubicin inhibits proliferation of triple-negative breast cancer through metabolic reprogramming. Oncogene 2023 Feb 9. doi: 10.1038/s41388-023-02608.
PMID: 36759576